Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 6,118 shares at $20.29 ($124K) on 2017-12-22, disclosed to the SEC on 2017-12-27.
Open-market sale of $124k CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.29 | 3,059 | $62K | 50.0% |
| 2 | $20.29 | 3,059 | $62K | 50.0% |
| Total | $20.29 avg | 6,118 | $124K | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |